Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. 

Biotechnology

Atomwise

Atomwise's headquarters in San Francisco, CA, United States

Steve Worland

Shakun Ohri

Paul Sprengeler

Kate Stafford

Denzil Bernard

Yan Zhao

Kemal Malik

Mike Varney

John Hamer

Andrew W. Lo

Robert Mittendorf

Description

People (13)

Cheng Hu

Yan Zhao

Pieter Kwak

Ed Kawashiri

Pamela Tsuruda

Niel Henriksen

Mostafa Ahmed

Denzil Bernard

Kate Stafford

Brad Worley

Kyle Giesler

Jordi Silvestre-Ryan

Michael Wimpee

Jobs